EarningsQ3 2024 Earnings Report

Moderna (MRNA) Q3 2024 Earnings Report

1 Followers

MX:MRNA Q3 2024 EPS Results

Actual EPS$0.54

Consensus EPS-$32.78

Beat/MissBeat by +$33.33

One Year Ago EPS-$173.09

Actual Revenue$33.82B

Expected Revenue$22.70B

Beat/MissBeat by +$11.11B

YoY Revenue Growth+1.69%

QuarterQ3 2024

Date11/07/2024

TimeBefore Open

Conference CallThursday, November 7, 2024

MX:MRNA Upcoming Earnings

Moderna's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

MX:MRNA Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	-20.01 / -	-9.263	―
Jul 31, 2026	2026 (Q2)	-36.91 / -35.78	-38.686	7.51% (+2.91)
May 01, 2026	2026 (Q1)	-80.75 / -61.75	-45.769	-34.92% (-15.98)
Feb 13, 2026	2025 (Q4)	-46.20 / -38.32	-52.852	27.49% (+14.53)
Nov 06, 2025	2025 (Q3)	-34.05 / -9.26	0.545	-1800.00% (-9.81)
Aug 01, 2025	2025 (Q2)	-54.29 / -38.69	-60.481	36.04% (+21.79)
May 01, 2025	2025 (Q1)	-56.59 / -45.77	-55.758	17.92% (+9.99)
Feb 14, 2025	2024 (Q4)	-48.68 / -52.85	9.989	-629.09% (-62.84)
Nov 07, 2024	2024 (Q3)	-32.78 / 0.54	-173.087	100.31% (+173.63)
Aug 01, 2024	2024 (Q2)	-60.81 / -60.48	-65.748	8.01% (+5.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed